Viemed Healthcare, Inc. (VMD): Price and Financial Metrics


Viemed Healthcare, Inc. (VMD): $7.40

0.02 (+0.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VMD POWR Grades

  • Quality is the dimension where VMD ranks best; there it ranks ahead of 97.43% of US stocks.
  • The strongest trend for VMD is in Growth, which has been heading down over the past 179 days.
  • VMD ranks lowest in Growth; there it ranks in the 16th percentile.

VMD Stock Summary

  • The ratio of debt to operating expenses for VIEMED HEALTHCARE INC is higher than it is for about only 12.35% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.25 for VIEMED HEALTHCARE INC; that's greater than it is for merely 15.27% of US stocks.
  • With a year-over-year growth in debt of -36.88%, VIEMED HEALTHCARE INC's debt growth rate surpasses just 8.26% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to VIEMED HEALTHCARE INC are PINC, AGX, III, IMXI, and CHE.
  • VMD's SEC filings can be seen here. And to visit VIEMED HEALTHCARE INC's official web site, go to www.viemed.com.

VMD Valuation Summary

  • VMD's EV/EBIT ratio is 23.7; this is 175.58% higher than that of the median Healthcare stock.
  • VMD's price/sales ratio has moved down 2.1 over the prior 40 months.

Below are key valuation metrics over time for VMD.

Stock Date P/S P/B P/E EV/EBIT
VMD 2022-11-25 2.0 2.9 34.4 23.7
VMD 2022-11-23 2.1 2.9 34.8 24.0
VMD 2022-11-22 2.0 2.8 33.4 23.0
VMD 2022-11-21 2.0 2.8 33.4 23.0
VMD 2022-11-18 2.0 2.8 33.1 22.8
VMD 2022-11-17 2.0 2.8 33.6 23.1

VMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VMD has a Quality Grade of B, ranking ahead of 93.39% of graded US stocks.
  • VMD's asset turnover comes in at 1.029 -- ranking 20th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows VMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.029 0.627 0.182
2021-06-30 1.069 0.614 0.202
2021-03-31 1.204 0.606 0.353
2020-12-31 1.234 0.610 0.396
2020-09-30 1.151 0.593 0.354
2020-06-30 1.150 0.628 0.338

VMD Price Target

For more insight on analysts targets of VMD, see our VMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $11.33 Average Broker Recommendation 1.5 (Moderate Buy)

VMD Stock Price Chart Interactive Chart >

Price chart for VMD

VMD Price/Volume Stats

Current price $7.40 52-week high $8.06
Prev. close $7.38 52-week low $3.56
Day low $7.29 Volume 35,600
Day high $7.43 Avg. volume 137,575
50-day MA $6.44 Dividend yield N/A
200-day MA $5.83 Market Cap 293.34M

Viemed Healthcare, Inc. (VMD) Company Bio


Viemed Healthcare, Inc. provides health care services. The Company offers respiratory disease management, neuromuscular care, home sleep testing, equipment solutions, sleep apnea treatment, and oxygen therapy services. Viemed Healthcare also offers rental of ventilator and peripheral equipment. Viemed Healthcare serves patients in the United States.


VMD Latest News Stream


Event/Time News Detail
Loading, please wait...

VMD Latest Social Stream


Loading social stream, please wait...

View Full VMD Social Stream

Latest VMD News From Around the Web

Below are the latest news stories about VIEMED HEALTHCARE INC that investors may wish to consider to help them evaluate VMD as an investment opportunity.

Viemed Announces New Senior Secured Credit Facilities

LAFAYETTE, La., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has entered into new syndicated credit facilities, consisting of a five-year senior secured revolving credit facility of up to $30 million and a five-year delayed draw term loan facility of up to $30 million, which may be borrowed in multiple drawdowns. The

Yahoo | November 29, 2022

7 Best Stocks to Buy Under $7

If you only have a few bucks to spare for investing, these are the best stocks to buy under $7 that bargain hunters should target.

Josh Enomoto on InvestorPlace | November 12, 2022

Viemed Healthcare GAAP EPS of $0.03 misses by $0.01, revenue of $35.8M beats by $1M

  • Viemed Healthcare press release (NASDAQ:VMD): Q3 GAAP EPS of $0.03 misses by $0.01.
  • Revenue of $35.8M (+22.2% Y/Y) beats by $1M.
...

Seeking Alpha | November 1, 2022

Viemed Healthcare Announces Third Quarter 2022 Financial Results

LAFAYETTE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2022. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended September 30, 2022 were $35.

Yahoo | November 1, 2022

Viemed Healthcare Announces Date and Time for Conference Call

LAFAYETTE, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Wednesday, November 2, 2022 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)201-689-8451 (International) Financial professionals are invited to call in to re

Yahoo | October 20, 2022

Read More 'VMD' Stories Here

VMD Price Returns

1-mo 9.14%
3-mo 27.37%
6-mo 34.55%
1-year 41.49%
3-year 21.91%
5-year N/A
YTD 41.76%
2021 -32.73%
2020 25.16%
2019 63.16%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.649 seconds.